Clinical Trial Update: Natural Killer Cell (CYNK-001) Infusions in Adults with AML [Phase 1]

View source ↗

Summary

Phase 1 trial examining CYNK-001 natural killer cell infusions in adults with acute myeloid leukemia; the study was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Leukemia

Drugs mentioned

• CYNK-001

Snippet

Sponsor: Celularity Incorporated | Conditions: Leukemia, Leukemia, Myeloid | Phase 1 | Status: TERMINATED